NO770161L - Tiazolidinderivater og fremgangsm}te til deres fremstilling. - Google Patents
Tiazolidinderivater og fremgangsm}te til deres fremstilling.Info
- Publication number
- NO770161L NO770161L NO770161A NO770161A NO770161L NO 770161 L NO770161 L NO 770161L NO 770161 A NO770161 A NO 770161A NO 770161 A NO770161 A NO 770161A NO 770161 L NO770161 L NO 770161L
- Authority
- NO
- Norway
- Prior art keywords
- chloro
- sulfamoyl
- compounds
- methyl
- bromo
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical class C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 title 1
- 230000008569 process Effects 0.000 claims abstract description 13
- 150000003548 thiazolidines Chemical class 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 77
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 19
- -1 alkyl isocyanates Chemical class 0.000 claims description 19
- 229910052794 bromium Inorganic materials 0.000 claims description 12
- 239000000460 chlorine Substances 0.000 claims description 12
- 229910052801 chlorine Inorganic materials 0.000 claims description 12
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 150000002431 hydrogen Chemical group 0.000 claims description 11
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 230000000054 salidiuretic effect Effects 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 239000005864 Sulphur Substances 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 150000001767 cationic compounds Chemical class 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 229910001411 inorganic cation Inorganic materials 0.000 claims description 2
- 150000002540 isothiocyanates Chemical class 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- 150000002892 organic cations Chemical class 0.000 claims description 2
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 2
- HUHRMYZEIGDUTR-UHFFFAOYSA-N sulfurochloridic acid;1,3-thiazolidine Chemical class C1CSCN1.OS(Cl)(=O)=O HUHRMYZEIGDUTR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 1
- 238000002844 melting Methods 0.000 description 51
- 230000008018 melting Effects 0.000 description 51
- 238000000354 decomposition reaction Methods 0.000 description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 34
- 239000002904 solvent Substances 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 14
- YQDHWZBHSROZSQ-UHFFFAOYSA-N methylazanium;n-methylcarbamothioate Chemical compound [NH3+]C.CNC([O-])=S YQDHWZBHSROZSQ-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 238000003756 stirring Methods 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- MYDXKJGPDBVJSF-UHFFFAOYSA-N 2-bromo-6-chloro-3-oxo-1,2-dihydroindene-5-sulfonamide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1CC(Br)C2=O MYDXKJGPDBVJSF-UHFFFAOYSA-N 0.000 description 11
- TXNZZKXIJJSNFH-UHFFFAOYSA-N 5-(2-bromoacetyl)-2-chlorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC(C(=O)CBr)=CC=C1Cl TXNZZKXIJJSNFH-UHFFFAOYSA-N 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 11
- 238000003776 cleavage reaction Methods 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 230000007017 scission Effects 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000007795 chemical reaction product Substances 0.000 description 9
- CLNJKWUFFSDNLL-UHFFFAOYSA-N methylazanium;n-methylcarbamodithioate Chemical compound NC.CNC(S)=S CLNJKWUFFSDNLL-UHFFFAOYSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 8
- 239000012299 nitrogen atmosphere Substances 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- JBAUKLKHGPSIDV-UHFFFAOYSA-N ethylazanium;n-ethylcarbamothioate Chemical compound CC[NH3+].CCNC([O-])=S JBAUKLKHGPSIDV-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- RBICFUXLAZTESJ-UHFFFAOYSA-N 5-(2-bromopropanoyl)-2-chlorobenzenesulfonamide Chemical compound CC(Br)C(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 RBICFUXLAZTESJ-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 239000000155 melt Substances 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- WGJCBBASTRWVJL-UHFFFAOYSA-N 1,3-thiazolidine-2-thione Chemical compound SC1=NCCS1 WGJCBBASTRWVJL-UHFFFAOYSA-N 0.000 description 4
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 4
- AFMYAHFFZZMHAI-UHFFFAOYSA-N 2-bromo-6-chloro-3-oxo-n-propyl-1,2-dihydroindene-5-sulfonamide Chemical compound C1=C(Cl)C(S(=O)(=O)NCCC)=CC2=C1CC(Br)C2=O AFMYAHFFZZMHAI-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical group COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 4
- YHVCFOAIWQCITB-UHFFFAOYSA-N n-benzyl-2-bromo-6-chloro-3-oxo-1,2-dihydroindene-5-sulfonamide Chemical compound ClC1=CC=2CC(Br)C(=O)C=2C=C1S(=O)(=O)NCC1=CC=CC=C1 YHVCFOAIWQCITB-UHFFFAOYSA-N 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- HPLLGVUYBDJDBR-UHFFFAOYSA-N 2-bromo-5-(2-bromoacetyl)benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC(C(=O)CBr)=CC=C1Br HPLLGVUYBDJDBR-UHFFFAOYSA-N 0.000 description 3
- RULHTFUDOITGLS-UHFFFAOYSA-N 2-bromo-6-chloro-2-methyl-3-oxo-1h-indene-5-sulfonamide Chemical compound ClC1=C(S(N)(=O)=O)C=C2C(=O)C(C)(Br)CC2=C1 RULHTFUDOITGLS-UHFFFAOYSA-N 0.000 description 3
- APGHLHRVZIZNHS-UHFFFAOYSA-N 2-methylpropan-1-amine;2-methylpropylcarbamothioic s-acid Chemical compound CC(C)C[NH3+].CC(C)CNC([O-])=S APGHLHRVZIZNHS-UHFFFAOYSA-N 0.000 description 3
- MRIAUTADXDMLTL-UHFFFAOYSA-N 5-(2-bromoacetyl)-2-chloro-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC(C(=O)CBr)=CC=C1Cl MRIAUTADXDMLTL-UHFFFAOYSA-N 0.000 description 3
- TUURWJRLUXOCDV-UHFFFAOYSA-N 6-chloro-3-oxo-1,2-dihydroindene-5-sulfonyl chloride Chemical compound C1=C(S(Cl)(=O)=O)C(Cl)=CC2=C1C(=O)CC2 TUURWJRLUXOCDV-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QNXSIUBBGPHDDE-UHFFFAOYSA-N alpha-indanone Natural products C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 3
- 239000012990 dithiocarbamate Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- XSBNNDUUIRIBKE-UHFFFAOYSA-N ethanamine;ethylcarbamodithioic acid Chemical compound CCN.CCNC(S)=S XSBNNDUUIRIBKE-UHFFFAOYSA-N 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 230000002140 halogenating effect Effects 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000001226 reprecipitation Methods 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L sodium sulphate Substances [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical class OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 150000003585 thioureas Chemical class 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- QTFDRWZRUOIWQI-UHFFFAOYSA-N 2-chloro-5-(2-chloroacetyl)benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC(C(=O)CCl)=CC=C1Cl QTFDRWZRUOIWQI-UHFFFAOYSA-N 0.000 description 2
- ZTNOLHMGIYLFGY-UHFFFAOYSA-N 2-chloro-5-(2-sulfanylacetyl)benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC(C(=O)CS)=CC=C1Cl ZTNOLHMGIYLFGY-UHFFFAOYSA-N 0.000 description 2
- JIVPVXMEBJLZRO-CQSZACIVSA-N 2-chloro-5-[(1r)-1-hydroxy-3-oxo-2h-isoindol-1-yl]benzenesulfonamide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC([C@@]2(O)C3=CC=CC=C3C(=O)N2)=C1 JIVPVXMEBJLZRO-CQSZACIVSA-N 0.000 description 2
- FFFWTYSDVPXMMS-UHFFFAOYSA-N 5-(2-bromoacetyl)-2-chloro-n-[(4-methylphenyl)methyl]benzenesulfonamide Chemical compound C1=CC(C)=CC=C1CNS(=O)(=O)C1=CC(C(=O)CBr)=CC=C1Cl FFFWTYSDVPXMMS-UHFFFAOYSA-N 0.000 description 2
- AHZBHCUELFAKJQ-UHFFFAOYSA-N 5-(2-bromobutanoyl)-2-chlorobenzenesulfonamide Chemical compound CCC(Br)C(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 AHZBHCUELFAKJQ-UHFFFAOYSA-N 0.000 description 2
- ZCGMYDCOEKHOKL-UHFFFAOYSA-N 5-chloro-2-methyl-6-nitro-2,3-dihydroinden-1-one Chemical compound ClC1=C([N+]([O-])=O)C=C2C(=O)C(C)CC2=C1 ZCGMYDCOEKHOKL-UHFFFAOYSA-N 0.000 description 2
- CYKKWXVKSIKLJM-UHFFFAOYSA-N 5-chloro-6-nitro-2,3-dihydroinden-1-one Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC2=C1CCC2=O CYKKWXVKSIKLJM-UHFFFAOYSA-N 0.000 description 2
- PHFHXNRLFZLFOO-UHFFFAOYSA-N 6-amino-5-chloro-2,3-dihydroinden-1-one Chemical compound C1=C(Cl)C(N)=CC2=C1CCC2=O PHFHXNRLFZLFOO-UHFFFAOYSA-N 0.000 description 2
- IYNCNZLPXKRMPN-UHFFFAOYSA-N 6-chloro-2-methyl-3-oxo-1,2-dihydroindene-5-sulfonamide Chemical compound ClC1=C(S(N)(=O)=O)C=C2C(=O)C(C)CC2=C1 IYNCNZLPXKRMPN-UHFFFAOYSA-N 0.000 description 2
- HQISRPOGFDYATG-UHFFFAOYSA-N 6-chloro-2-methyl-3-oxo-1,2-dihydroindene-5-sulfonyl chloride Chemical compound ClC1=C(S(Cl)(=O)=O)C=C2C(=O)C(C)CC2=C1 HQISRPOGFDYATG-UHFFFAOYSA-N 0.000 description 2
- WOHKJXGEOBJPGB-UHFFFAOYSA-N 6-chloro-3-oxo-1,2-dihydroindene-5-sulfonamide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1CCC2=O WOHKJXGEOBJPGB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- RPTUSVTUFVMDQK-UHFFFAOYSA-N Hidralazin Chemical compound C1=CC=C2C(NN)=NN=CC2=C1 RPTUSVTUFVMDQK-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 229960001523 chlortalidone Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- ODQARBNNGUIGNI-UHFFFAOYSA-N propan-2-ylazanium;n-propan-2-ylcarbamodithioate Chemical compound CC(C)N.CC(C)NC(S)=S ODQARBNNGUIGNI-UHFFFAOYSA-N 0.000 description 2
- FAUZYUVQHCOZST-UHFFFAOYSA-N propan-2-ylazanium;n-propan-2-ylcarbamothioate Chemical compound CC(C)[NH3+].CC(C)NC([O-])=S FAUZYUVQHCOZST-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- QOKILILPOIVYQB-UHFFFAOYSA-N propylazanium;n-propylcarbamodithioate Chemical compound CCC[NH3+].CCCNC([S-])=S QOKILILPOIVYQB-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 125000000565 sulfonamide group Chemical group 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- PWMWNFMRSKOCEY-UHFFFAOYSA-N 1-Phenyl-1,2-ethanediol Chemical compound OCC(O)C1=CC=CC=C1 PWMWNFMRSKOCEY-UHFFFAOYSA-N 0.000 description 1
- OTVGARFFAAFRAC-UHFFFAOYSA-N 2-bromo-1,4-dioxane Chemical compound BrC1COCCO1 OTVGARFFAAFRAC-UHFFFAOYSA-N 0.000 description 1
- LRZJXAWNFMXCKO-UHFFFAOYSA-N 2-methylpropylazanium;n-(2-methylpropyl)carbamodithioate Chemical compound CC(C)C[NH3+].CC(C)CNC([S-])=S LRZJXAWNFMXCKO-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- BYRBYIGGQSDHMO-UHFFFAOYSA-N 3-(2-chloroacetyl)benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(C(=O)CCl)=C1 BYRBYIGGQSDHMO-UHFFFAOYSA-N 0.000 description 1
- AXAPSRCVYPMZFD-UHFFFAOYSA-N 3-(4-hydroxy-1,3-thiazolidin-4-yl)benzenesulfonamide Chemical class NS(=O)(=O)C1=CC=CC(C2(O)NCSC2)=C1 AXAPSRCVYPMZFD-UHFFFAOYSA-N 0.000 description 1
- RRHSDGPLLWXDMS-UHFFFAOYSA-N 5-(2-bromoacetyl)-2,4-dichlorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC(C(=O)CBr)=C(Cl)C=C1Cl RRHSDGPLLWXDMS-UHFFFAOYSA-N 0.000 description 1
- XWDIJPOBZQJHIE-UHFFFAOYSA-N 5-(2-bromoacetyl)-2-chloro-n-propylbenzenesulfonamide Chemical compound CCCNS(=O)(=O)C1=CC(C(=O)CBr)=CC=C1Cl XWDIJPOBZQJHIE-UHFFFAOYSA-N 0.000 description 1
- ZSCLDBDOQXVRKS-UHFFFAOYSA-N 5-(2-bromopropanoyl)-2-chloro-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC(C(=O)C(C)Br)=CC=C1Cl ZSCLDBDOQXVRKS-UHFFFAOYSA-N 0.000 description 1
- MEDSHTHCZIOVPU-UHFFFAOYSA-N 5-chloro-2,3-dihydroinden-1-one Chemical compound ClC1=CC=C2C(=O)CCC2=C1 MEDSHTHCZIOVPU-UHFFFAOYSA-N 0.000 description 1
- RNMXBENXOQYACE-UHFFFAOYSA-N 5-chloro-2-methyl-2,3-dihydroinden-1-one Chemical compound ClC1=CC=C2C(=O)C(C)CC2=C1 RNMXBENXOQYACE-UHFFFAOYSA-N 0.000 description 1
- HXLRDBIOOKHWKV-UHFFFAOYSA-N 6-amino-5-chloro-2-methyl-2,3-dihydroinden-1-one Chemical compound ClC1=C(N)C=C2C(=O)C(C)CC2=C1 HXLRDBIOOKHWKV-UHFFFAOYSA-N 0.000 description 1
- MSCVURZPOJKQTH-UHFFFAOYSA-N 6-chloro-3-oxo-n-propyl-1,2-dihydroindene-5-sulfonamide Chemical compound C1=C(Cl)C(S(=O)(=O)NCCC)=CC2=C1CCC2=O MSCVURZPOJKQTH-UHFFFAOYSA-N 0.000 description 1
- JBMKAUGHUNFTOL-UHFFFAOYSA-N Aldoclor Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC=NS2(=O)=O JBMKAUGHUNFTOL-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 240000001546 Byrsonima crassifolia Species 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 238000007192 Meerwein reaction reaction Methods 0.000 description 1
- GSCCALZHGUWNJW-UHFFFAOYSA-N N-Cyclohexyl-N-methylcyclohexanamine Chemical compound C1CCCCC1N(C)C1CCCCC1 GSCCALZHGUWNJW-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- GJEAMHAFPYZYDE-UHFFFAOYSA-N [C].[S] Chemical compound [C].[S] GJEAMHAFPYZYDE-UHFFFAOYSA-N 0.000 description 1
- YBGJZYCWGNYUMA-UHFFFAOYSA-M [Cl-].[P+]=O Chemical compound [Cl-].[P+]=O YBGJZYCWGNYUMA-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000002170 aldosterone antagonist Substances 0.000 description 1
- 229940083712 aldosterone antagonist Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- SKOLWUPSYHWYAM-UHFFFAOYSA-N carbonodithioic O,S-acid Chemical class SC(S)=O SKOLWUPSYHWYAM-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- RMXVHZFHSKRNJN-UHFFFAOYSA-N chlorourea Chemical compound NC(=O)NCl RMXVHZFHSKRNJN-UHFFFAOYSA-N 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000004659 dithiocarbamates Chemical class 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- ACGDKVXYNVEAGU-UHFFFAOYSA-N guanethidine Chemical compound NC(N)=NCCN1CCCCCCC1 ACGDKVXYNVEAGU-UHFFFAOYSA-N 0.000 description 1
- 229960003602 guanethidine Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002474 hydralazine Drugs 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052806 inorganic carbonate Inorganic materials 0.000 description 1
- 229910001853 inorganic hydroxide Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- JZNKQPWUZZITQT-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)carbamodithioate;triethylazanium Chemical compound CC[NH+](CC)CC.[S-]C(=S)NCC1=CC=CC=N1 JZNKQPWUZZITQT-UHFFFAOYSA-N 0.000 description 1
- PVQWDBDZBOBENW-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)carbamothioate;triethylazanium Chemical compound CC[NH+](CC)CC.[O-]C(=S)NCC1=CC=CC=N1 PVQWDBDZBOBENW-UHFFFAOYSA-N 0.000 description 1
- JQNNERRZXQZCAZ-UHFFFAOYSA-N n-(pyridin-3-ylmethyl)carbamodithioate;triethylazanium Chemical compound CC[NH+](CC)CC.[S-]C(=S)NCC1=CC=CN=C1 JQNNERRZXQZCAZ-UHFFFAOYSA-N 0.000 description 1
- NFVVJOWYXNNVHY-UHFFFAOYSA-N n-benzyl-5-(2-bromoacetyl)-2-chlorobenzenesulfonamide Chemical compound ClC1=CC=C(C(=O)CBr)C=C1S(=O)(=O)NCC1=CC=CC=C1 NFVVJOWYXNNVHY-UHFFFAOYSA-N 0.000 description 1
- YWIONECDPRMOSC-UHFFFAOYSA-N n-benzyl-5-(2-bromopropanoyl)-2-chlorobenzenesulfonamide Chemical compound CC(Br)C(=O)C1=CC=C(Cl)C(S(=O)(=O)NCC=2C=CC=CC=2)=C1 YWIONECDPRMOSC-UHFFFAOYSA-N 0.000 description 1
- DQCHLYKWVMRVBU-UHFFFAOYSA-N n-benzyl-6-chloro-3-oxo-1,2-dihydroindene-5-sulfonamide Chemical compound ClC1=CC=2CCC(=O)C=2C=C1S(=O)(=O)NCC1=CC=CC=C1 DQCHLYKWVMRVBU-UHFFFAOYSA-N 0.000 description 1
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N n-cyclohexyl-n-ethylcyclohexanamine Chemical compound C1CCCCC1N(CC)C1CCCCC1 XRKQMIFKHDXFNQ-UHFFFAOYSA-N 0.000 description 1
- BUXKUERLVNOPIC-UHFFFAOYSA-N n-methyl-n-pyridin-4-ylcarbamodithioate;triethylazanium Chemical compound CC[NH+](CC)CC.[S-]C(=S)N(C)C1=CC=NC=C1 BUXKUERLVNOPIC-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- ZOCLAPYLSUCOGI-UHFFFAOYSA-M potassium hydrosulfide Chemical compound [SH-].[K+] ZOCLAPYLSUCOGI-UHFFFAOYSA-M 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- KJPMSOLJXZDPLN-UHFFFAOYSA-N propylazanium;n-propylcarbamothioate Chemical compound CCC[NH3+].CCCNC([O-])=S KJPMSOLJXZDPLN-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 230000000894 saliuretic effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 150000003566 thiocarboxylic acids Chemical class 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762601791 DE2601791A1 (de) | 1976-01-20 | 1976-01-20 | Thiazolidinderivate und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO770161L true NO770161L (no) | 1977-07-21 |
Family
ID=5967727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO770161A NO770161L (no) | 1976-01-20 | 1977-01-19 | Tiazolidinderivater og fremgangsm}te til deres fremstilling. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4129656A (da) |
| JP (1) | JPS5289669A (da) |
| AT (1) | AT356102B (da) |
| AU (1) | AU511547B2 (da) |
| BE (1) | BE850575A (da) |
| CA (1) | CA1078847A (da) |
| DE (1) | DE2601791A1 (da) |
| DK (1) | DK19777A (da) |
| ES (4) | ES455013A1 (da) |
| FI (1) | FI770142A (da) |
| FR (1) | FR2338937A1 (da) |
| GB (1) | GB1541974A (da) |
| HU (1) | HU175096B (da) |
| IE (1) | IE44213B1 (da) |
| IL (1) | IL51287A (da) |
| IT (1) | IT1077590B (da) |
| LU (1) | LU76597A1 (da) |
| NL (1) | NL7700381A (da) |
| NO (1) | NO770161L (da) |
| SE (1) | SE7700500L (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2737195A1 (de) * | 1977-08-18 | 1979-03-01 | Hoechst Ag | Benzolsulfonamidderivate und verfahren zu ihrer herstellung |
| DE19731782A1 (de) * | 1997-07-24 | 1999-01-28 | Bayer Ag | Verfahren zur Herstellung von Pyridylmethylisocyanaten |
| DE19908539A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10008274A1 (de) * | 2000-02-23 | 2001-08-30 | Aventis Pharma Gmbh | Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10142665B4 (de) * | 2001-08-31 | 2004-05-06 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-one und ihre Derivate |
| DE10142722A1 (de) * | 2001-08-31 | 2003-03-27 | Aventis Pharma Deutschland GmbH, 65929 Frankfurt | C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7271195B2 (en) * | 2003-06-10 | 2007-09-18 | Kalypsys, Inc. | Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| BRPI0411275A (pt) * | 2003-06-10 | 2006-08-01 | Kalypsys Inc | compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac |
| EP1773398A2 (en) * | 2004-06-10 | 2007-04-18 | Kalypsys, Inc. | Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| EP2202222A3 (en) * | 2005-11-08 | 2010-09-15 | Laboratorios Del Dr. Esteve, S.A. | Indene derivatives, their preparation and use as medicaments |
| EP1884515A1 (en) * | 2006-07-31 | 2008-02-06 | Laboratorios del Dr. Esteve S.A. | Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| US10392381B2 (en) | 2014-07-18 | 2019-08-27 | Ohio University | Prevention and treatment of non-alcoholic fatty liver disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3671534A (en) * | 1970-03-16 | 1972-06-20 | Sandoz Ag | 6,6-DI-LOWER ALKYL-2,3,5,6-TETRAHYDROIMIDAZO {8 2,1-b{9 {11 THIAZOLES |
| DE2546165A1 (de) * | 1975-10-15 | 1977-04-28 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
-
0
- SE SE7700500A patent/SE7700500L/xx unknown
-
1976
- 1976-01-20 DE DE19762601791 patent/DE2601791A1/de not_active Withdrawn
-
1977
- 1977-01-14 NL NL7700381A patent/NL7700381A/xx not_active Application Discontinuation
- 1977-01-14 ES ES455013A patent/ES455013A1/es not_active Expired
- 1977-01-18 FI FI770142A patent/FI770142A/fi not_active Application Discontinuation
- 1977-01-18 IL IL51287A patent/IL51287A/xx unknown
- 1977-01-18 US US05/760,411 patent/US4129656A/en not_active Expired - Lifetime
- 1977-01-18 IT IT19413/77A patent/IT1077590B/it active
- 1977-01-18 LU LU76597A patent/LU76597A1/xx unknown
- 1977-01-19 CA CA270,057A patent/CA1078847A/en not_active Expired
- 1977-01-19 AT AT28277A patent/AT356102B/de not_active IP Right Cessation
- 1977-01-19 NO NO770161A patent/NO770161L/no unknown
- 1977-01-19 AU AU21433/77A patent/AU511547B2/en not_active Expired
- 1977-01-19 IE IE98/77A patent/IE44213B1/en unknown
- 1977-01-19 DK DK19777A patent/DK19777A/da unknown
- 1977-01-20 HU HU77HO1953A patent/HU175096B/hu unknown
- 1977-01-20 BE BE174240A patent/BE850575A/xx unknown
- 1977-01-20 JP JP448377A patent/JPS5289669A/ja active Pending
- 1977-01-20 GB GB772315A patent/GB1541974A/en not_active Expired
- 1977-01-20 FR FR7701519A patent/FR2338937A1/fr active Granted
-
1978
- 1978-11-30 ES ES475558A patent/ES475558A1/es not_active Expired
- 1978-11-30 ES ES475557A patent/ES475557A1/es not_active Expired
- 1978-11-30 ES ES475559A patent/ES475559A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1541974A (en) | 1979-03-14 |
| HU175096B (hu) | 1980-05-28 |
| ATA28277A (de) | 1979-09-15 |
| SE7700500L (sv) | 1977-07-21 |
| FR2338937B1 (da) | 1980-03-28 |
| DK19777A (da) | 1977-07-21 |
| LU76597A1 (da) | 1977-07-27 |
| BE850575A (fr) | 1977-07-20 |
| DE2601791A1 (de) | 1977-07-21 |
| AU2143377A (en) | 1978-07-27 |
| JPS5289669A (en) | 1977-07-27 |
| IL51287A (en) | 1980-05-30 |
| AT356102B (de) | 1980-04-10 |
| IT1077590B (it) | 1985-05-04 |
| IE44213L (en) | 1977-07-20 |
| US4129656A (en) | 1978-12-12 |
| ES475558A1 (es) | 1979-05-16 |
| NL7700381A (nl) | 1977-07-22 |
| IL51287A0 (en) | 1977-03-31 |
| ES475559A1 (es) | 1979-05-01 |
| FI770142A (da) | 1977-07-21 |
| ES475557A1 (es) | 1979-05-01 |
| ES455013A1 (es) | 1979-05-01 |
| FR2338937A1 (fr) | 1977-08-19 |
| IE44213B1 (en) | 1981-09-09 |
| CA1078847A (en) | 1980-06-03 |
| AU511547B2 (en) | 1980-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO141163B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidiner | |
| SK282080B6 (sk) | Substituované salicylové kyseliny a ich použitie | |
| NO167947B (no) | Lagringsanordning for baand- eller plate-registreringsmedier | |
| NO770161L (no) | Tiazolidinderivater og fremgangsm}te til deres fremstilling. | |
| US4546191A (en) | Trifluoromethyl-2-pyridinone or pyridinthione compounds and process for the preparation of the same | |
| FI59253C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-hydroxi-2h-tieno(2,3-e) och (3,4-e)-1,2-tiazin-3-karboxamid-1,1-dioxid-derivat | |
| NO762661L (da) | ||
| US2595334A (en) | Benzothiazolesulfonamides and method of preparing the same | |
| CA1093081A (en) | Process for the production of aryl ureas | |
| AU2021100660A4 (en) | Substituted 3-Indazole MCL-1 Inhibitor, Preparation Method and Use Thereof | |
| NO762625L (da) | ||
| PL184860B1 (pl) | Chinoksaliny o własnościach leczniczychĆ zwłaszcza antywirusowychĆ sposób ich wytwarzania i środki lecznicze zawierające chinoksaliny jako substancje czynne | |
| Hultquist et al. | N-Heterocyclic benzenesulfonamides | |
| NO144528B (no) | Analogifremgangsmaate til fremstilling av thiazolidinderivater med diuretisk og saluretisk virkning | |
| NO814468L (no) | Tiazolinderivater, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser | |
| US2783240A (en) | Heterocyclic sulfonamides | |
| SE436743B (sv) | Forfarande for framstellning av 2,1,3-tiadiazin-4-on-2,2-dioxidderivat | |
| EP0170057B1 (de) | Verfahren zur Herstellung von N-Phenyl(Pyridyl)-sulfonyldiamiden | |
| Seto et al. | Cycloheptathiazole Derivatives. I. Synthesis of 7-Hydroxycyclohepta-[d] thiazol-6-one and its Derivatives | |
| JPS6325584B2 (da) | ||
| GB1570912A (en) | Aromatic sulphonamido derivatives and process for their manufacture | |
| US3801588A (en) | Certain perfluoroalkylsulfon-amidothiazoles | |
| Martinez-Merino et al. | NEW 5-SUBSTITUTED DERIVATIVES OF ETHYL 2, 3-DIHYDRO | |
| US3530124A (en) | 4-(5-nitro-2-thiazolyl)-thiomorpholine-oxides | |
| NO133892B (da) |